Horgan C - Search Results

1

In vivo studies with the novel anticancer agent mitozolomide (NSC 353451) on Lewis lung carcinoma.

Broggini M, Erba E, Morasca L, Horgan C, D'Incalci M. Broggini M, et al. Among authors: horgan c. Cancer Chemother Pharmacol. 1986;16(2):125-8. doi: 10.1007/BF00256161. Cancer Chemother Pharmacol. 1986. PMID: 3948297

2

Antitumour imidazotetrazines--VIII. Uptake and decomposition of a novel antitumour agent mitozolomide (CCRG 81010; M and B 39565; NSC 353451) in TLX5 mouse lymphoma in vitro.

Horgan CM, Tisdale MJ. Horgan CM, et al. Biochem Pharmacol. 1985 Jan 15;34(2):217-21. doi: 10.1016/0006-2952(85)90127-3. Biochem Pharmacol. 1985. PMID: 3966923

3

Antitumour imidazotetrazines--IV. An investigation into the mechanism of antitumour activity of a novel and potent antitumour agent, mitozolomide (CCRG 81010, M & B 39565; NSC 353451).

Horgan CM, Tisdale MJ. Horgan CM, et al. Biochem Pharmacol. 1984 Jul 15;33(14):2185-92. doi: 10.1016/0006-2952(84)90652-x. Biochem Pharmacol. 1984. PMID: 6147140

4

Complement-component-C3-opsonized immunoglobulin G anti-DNA antibodies do not bind effectively to red blood cells unless aggregated on a high-Mr DNA matrix.

Horgan C, Taylor RP. Horgan C, et al. Biochem J. 1984 Dec 15;224(3):755-9. doi: 10.1042/bj2240755. Biochem J. 1984. PMID: 6525175 Free PMC article.

5

The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3.

Ludbrook SB, Barry ST, Delves CJ, Horgan CM. Ludbrook SB, et al. Biochem J. 2003 Jan 15;369(Pt 2):311-8. doi: 10.1042/BJ20020809. Biochem J. 2003. PMID: 12358597 Free PMC article.

6

Quantitative determination of anti-dsDNA antibodies and antibody/dsDNA stoichiometries in prepared, soluble complement-fixing antibody/dsDNA immune complexes.

Taylor RP, Horgan C. Taylor RP, et al. Among authors: horgan c. Mol Immunol. 1984 Oct;21(10):853-62. doi: 10.1016/0161-5890(84)90139-1. Mol Immunol. 1984. PMID: 6334233

7

Suramin inhibits the binding of complement-fixing antibody/double-stranded DNA immune complexes to CR1.

Taylor RP, Horgan C, Harbin A, Burge J. Taylor RP, et al. Among authors: horgan c. Clin Immunol Immunopathol. 1984 Nov;33(2):220-31. doi: 10.1016/0090-1229(84)90077-1. Clin Immunol Immunopathol. 1984. PMID: 6488590

8

Studies on the kinetics of binding of complement-fixing dsDNA/anti-dsDNA immune complexes to the red blood cells of normal individuals and patients with systemic lupus erythematosus.

Horgan C, Taylor RP. Horgan C, et al. Arthritis Rheum. 1984 Mar;27(3):320-9. doi: 10.1002/art.1780270312. Arthritis Rheum. 1984. PMID: 6546694

9

Quantitative analyses of complement fixation in three immune complex systems.

Horgan C, Taylor RP. Horgan C, et al. Immunology. 1984 Aug;52(4):753-9. Immunology. 1984. PMID: 6611301 Free PMC article.

10

The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.

Taylor RP, Burge J, Horgan C, Shasby DM. Taylor RP, et al. Among authors: horgan c. J Immunol. 1983 Jun;130(6):2656-62. J Immunol. 1983. PMID: 6854016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters